BackgroundRNA N6-methyladenosine (m6A) regulators are considered post-transcriptional regulators that affect several biological functions, and their role in immunity, in particular, is emerging. However, the role of m6A regulators in respiratory allergic diseases remains unclear. Therefore, we aimed to investigate the role of key m6A regulators in mediating respiratory allergic diseases and immune microenvironment infiltration characteristics.MethodsWe downloaded gene expression profiles of respiratory allergies from the Gene Expression Omnibus (GEO) database and we performed hierarchical clustering, difference analysis, and construction of predictive models to identify hub m6A regulators that affect respiratory allergies. Next, we investigate the underlying biological mechanisms of key m6A regulators by performing PPI network analysis, functional enrichment analysis, and immune microenvironment infiltration analysis. In addition, we performed a drug sensitivity analysis on the key m6A regulator, hoping to be able to provide some implications for clinical medication.ResultsIn this study, we identified four hub m6A regulators that affect the respiratory allergy and investigated the underlying biological mechanisms. In addition, studies on the characteristics of immune microenvironment infiltration revealed that the expression ofMETTL14,METTL16, andRBM15Bcorrelated with the infiltration of the mast and Th2 cells in respiratory allergy, andMETTL16expression was found to be significantly negatively correlated with macrophages for the first time (R = -0.53,P< 0.01). Finally, a key m6A regulator,METTL14, was screened by combining multiple algorithms. In addition, by performing a drug sensitivity analysis onMETTL14,we hypothesized that it may play an important role in the improvement of allergic symptoms in the upper and lower airways with topical nasal glucocorticoids.ConclusionsOur findings suggest that m6A regulators, particularlyMETTL14, play a crucial role in the development of respiratory allergic diseases and the infiltration of immune cells. These results may provide insight into the mechanism of action of methylprednisolone in treating respiratory allergic diseases.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12890-023-02499-0.